Table 3.
Case | pT/pN | BRAFV600E | CPE | Cytoplasmic CLDN4 | Nuclear YAP |
---|---|---|---|---|---|
1 | pT3/pN0 | − | − | − | − |
2 | pT3/pN0 | − | − | − | − |
3 | pT3/pN0 | − | − | − | − |
4 | pT3/pN1 | − | − | − | − |
5 | pT3/pN0 | + | − | − | − |
6 | pT3/pN1 | + | − | − | − |
7 | pT3/pN1 | + | − | − | − |
8 | pT3/pN0 | + | + | + | + |
9 | pT3/pN1 | + | + | + | + |
10 | pT3/pN2 | + | + | + | + |
CPE, Clostridium perfringens enterotoxin; pT3, invasion into subserosal layer; pN1, metastasis to 1–3 regional lymph node(s); pN2, metastasis to 3 or more regional lymph nodes.